MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

Lancet Neurology

Volumn 6, Issue 8, 2007, Pages 677-686

  Swanton, Josephine K ^a   Rovira, Alex ^b   Tintore, Mar ^b   Altmann, Daniel R ^a,c   Barkhof, Frederik ^d   Filippi, Massimo ^e   Huerga, Elena ^b   Miszkiel, Katherine A ^f   Plant, Gordon T ^g   Polman, Chris ^d   Rovaris, Marco ^e   Thompson, Alan J ^a   Montalban, Xavier ^b   Miller, David H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^g MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; BRAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SYNDROME;

EID: 34447506320     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70176-X     Document Type: Article

References (33)

1. Ormerod I., Bronstein A., Rudge P., et al. Magnetic resonance imaging in clinically isolated lesions of the brain stem. J Neurol Neurosurg Psychiatry 49 (1986) 737-743
2. Ormerod I., McDonald W., du Boulay G., et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 49 (1986) 124-127
3. Jacobs L., Kinkel P., and Kinkel W. Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study. Arch Neurol 43 (1986) 452-455
4. Brex P., Ciccarelli O., O'Riordan J., et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346 (2002) 158-164
5. Beck R., Trobe J., Moke P., et al. High and low risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121 (2003) 944-949
6. Minneboo A., Barkhof F., Polman C., et al. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61 (2004) 217-221
7. Tintore M., Rovira A., Rio J., et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67 (2006) 968-972
8. Korteweg T., Tintore M., Uitdehaag B., et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 5 (2006) 221-227
9. Barkhof F., Filippi M., Miller D., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
10. Tintore M., Rovira A., Martinez M., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 21 (2000) 702-706
11. McDonald W., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
12. Dalton C., Brex P., Miszkiel K., et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 52 (2002) 47-53
13. Tintore M., Rovira A., Rio J., et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 60 (2003) 27-30
14. Dalton C., Brex P., Miszkiel K., et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 53 (2003) 673-676
15. Polman C., Reingold S., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
16. Swanton J., Fernando K., Dalton C., et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77 (2006) 830-833
17. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
18. Poser C., Paty D., Sceinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
19. Kappos L., Moeri D., Radue E., et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability of impairment in multiple sclerosis: a meta-analysis. Lancet 353 (1999) 964-969
20. Bot J., Barkhof F., Polman C., et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62 (2004) 226-233
21. Thorpe J., Kidd D., Moseley I., et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46 (1996) 373-378
22. Bot J., Barkhof F., Lycklama à Nijeholt G., et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223 (2002) 46-56
23. Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 68 (1983) 371-377
24. Rizzo J., and Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long term prospective study. Neurology 38 (1988) 185-190
25. Tintore M., Rovira A., Rio J., et al. Is optic neuritis more benign than other first attacks in multiple sclerosis?. Ann Neurol 57 (2005) 210-215
26. Swanton J., Fernando K., Dalton C., et al. Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J Neurol Neurosurg Psychiatry 77 (2006) 1070-1072
27. Jacobs L., Beck R., Simon J., et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343 (2000) 898-904
28. Comi G., Filippi M., Barkhof F., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357 (2001) 1576-1582
29. Kappos L., Polman C., Freedman M., et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67 (2006) 1242-1249
30. Ebers G. Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol 252 suppl 3 (2005) III15-III20
31. Ramsaransing G., Maurits N., Zwankikken C., and De Keyser J. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 7 (2001) 345-347
32. Confavreux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003) 770-782
33. Wattjes M., Lutterbey G., Gieseke J., et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. Am J Neuroradiol 28 (2007) 54-59